Prostate-specific antigen best practice policy-part I: early detection and diagnosis of prostate cancer

By Carroll P.   Coley C.   McLeod D.   Schellhammer P.   Sweat G.   Wasson J.   Zietman A.   Thompson I.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Follow-Up of Men with Elevated Prostate-Specific Antigen and One Set of Benign Biopsies at Prostate Cancer Screening

By Zackrisson B.   Aus G.   Lilja H.   Lodding P.   Pihl C.-G.   Hugosson J.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Prostate-Specific Antigen for Prostate Cancer Staging in a Population-based Register

By Sandblom G.   Holmberg L.   Damber J.-E.   Hugosson J.   Johansson J.-E.   Lundgren R.   Mattsson E.   Nilsson J.   Varenhorst E.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 2, 2002-04 ,pp. : 99-105

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up 1

By Grossfeld G.D.   Litwin M.S.   Wolf J.S.   Hricak H.   Shuler C.L.   Agerter D.C.   Carroll P.R.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 604-610

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite